200 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Protozoan Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
5 Recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
Intervention:
6 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Recruiting Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
8 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
9 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
10 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
11 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
12 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
13 Unknown  Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
14 Recruiting Adherence to Antimalarial Drugs in Sierra Leone
Condition: Malaria
Interventions: Drug: amodiaquine-artesunate (AQAS) co-formulated;   Drug: Artemether-lumefantrine combination (AL)
15 Unknown  Human Immunity to MSP-1 in Western Kenya
Condition: Plasmodium Falciparum Malaria
Intervention:
16 Not yet recruiting Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector
Conditions: Fever;   Malaria
Interventions: Other: Free Malaria Rapid Diagnostic Test;   Other: Conditional ACT voucher;   Other: Malaria Rapid Diagnostic test for a charge
17 Recruiting New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
Condition: Chagas Disease
Intervention: Drug: Benznidazole
18 Unknown  Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Condition: Ocular Toxoplasmosis
Intervention: Drug: Trimethoprim-Sulfamethoxazole
19 Recruiting A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5
Conditions: Malaria;   Plasmodium Falciparum
Interventions: Biological: ChAd63 RH5 low dose;   Biological: ChAd63 RH5 full dose;   Biological: MVA RH5 low dose;   Biological: MVA RH5 full dose
20 Recruiting The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Condition: Malaria Transmission
Interventions: Drug: Artemether Lumefantrine;   Drug: Artemether Lumefantrine 6 dose regimen & single dose of Primaquine on day 0;   Drug: Artemether Lumefantrine 6 dose regimen and single dose Primaquine on day 2

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years